SPY334.33+2.22 0.67%
DIA273.90+1.90 0.70%
IXIC11,108.07+109.67 1.00%

Urovant Sciences Q2 EPS $(0.85) Beats $(1.15) Estimate

Urovant Sciences (NASDAQ:UROV) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(1.15) by 26.09 percent. This is a 30.89 percent increase over losses of $(1.23) per share from

Benzinga · -

Urovant Sciences (NASDAQ:UROV) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(1.15) by 26.09 percent. This is a 30.89 percent increase over losses of $(1.23) per share from the same period last year.